Please login to the form below
NET
This page shows the latest NET news and features for those working in and with pharma, biotech and healthcare.
Bayer bulks up in women’s health again with non-hormonal contraceptive deal
It is designed to slowly release a local-acting agent that reduces sperm motility, coupled with a polymer ‘net’ that physically blocks sperm from entering the cervical canal. ... to $310m, as well as double-digit tiered royalties on net sales.
Latest news
-
AbbVie creates new aesthetics division amid Allergan takeover
It used net proceeds from the sale to fund a portion of the cash consideration due to Allergan shareholders in connection with the acquisition, and to pay related fees and expenses.
-
Roche pays $1.15bn for Sarepta’s Duchenne gene therapy
7bn in regulatory and sales milestones, plus royalties on net sales.
-
AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
The revised report also determined that Xeljanz had a comparable net health benefit to Humira, while there is no evidence to compare Olumiant to the older treatment.
-
AbbVie sells $30bn of bonds ahead of Allergan merger
Will use net proceeds to fund cash consideration due to shareholders. ... AbbVie will use the net proceeds from the sale to fund a portion of the cash consideration due to Allergan shareholders, in connection with the acquisition, and to pay related fees
-
Externalities
Let’s give away insecticide-treated nets (ITNs) to prevent malaria or make vaccines free at the point of care.
More from news
Approximately 9 fully matching, plus 714 partially matching documents found.
Latest Intelligence
-
Driving the innovation engine
It’s really a matter of boundaries – how and where you cast the net.
-
What pharma marketers can learn from Disney
But is pharma utilising them to their full potential? Should we be analysing customer experience metrics such as net promoter score, customer satisfaction, churn rate, retention rate, customer lifetime value and
-
Vertex: a vision of treating all CF patients worldwide draws closer
a loss in almost all of its 20+ years, and has cumulative net losses of around $3bn.
-
The UK’s new five-year pricing agreement
payments based on net sales.
-
Deal Watch October 2018
based on net product sales”. ... So, what’s the score overall? Based on the actual payments (excluding milestones and royalties) Novartis has paid out $2.14B and received $1.46B; a net payout of $680m, while
More from intelligence
Approximately 1 fully matching, plus 79 partially matching documents found.
Latest appointments
-
Ceri James joins AZoNetwork as chief operating officer
He will be heavily involved in the commercial development of Newsmedical.net as well as the evolution and increasing headcount of the sales and marketing teams.”.
-
M3 appoints Simon Walker as director of education
Prior to his new appointment, Walker was a business director at M3, whose channels include doctors.net.uk and Networks in Health.
-
Wilmington Healthcare appoints managing director
Previously, Thomas served as international development director for Doctors.net.uk - part of the M3 Group - and was responsible for setting up global physician online community alliance Networks in Health.
-
Lucid appoints trio of new starters
These qualities are often found in new graduates, which is why we set up the Futures Programme - to make sure we don't let people like Chloe slip through the net.
-
M3 Europe appoints new business director
M3 Europe's businesses include the online physician networks doctors.net.uk and Networks in Health.
More from appointments
Approximately 2 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Looking after the mental health of the Porterhouse family
For our employees who would prefer to speak to somebody outside of the work environment, Porterhouse is also signed up to the Mindful Employer charter ( www.mindfulemployer.net).
-
Innovative pricing and contracting options
Widening the gross-to-net ratio via innovative net pricing schemes (discounts and rebates) can drive volume among price sensitive payers. ... 3. For new entrants in the biologics space, adopting net pricing options is crucial since some US payers are
-
Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis
Available at: https://www.rarediseaseday.org/page/news/watch-new-patient-videos-for-rare-disease-day-2019-2. Accessed February 2019. About rare diseases. Available at:
-
The 10-year Web Challenge
The reality is the opposite: the net is infinite, there are countless websites available, countless sites that are similar to the one you are currently creating – and users have a fairly
-
Givers and Takers
Have we lost the ability to identify the difference between net givers and net takers of energy? ... In his mind it was clear – net takers failed to recognise the evil within themselves.
More from PMHub
Approximately 14 fully matching, plus 73 partially matching documents found.
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Consultant
-
competitive salary
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Account Director or Senior Account Director
-
Salary TBC
-
Vice President
-
Competitive Salary Offered
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
Subscribe to our email news alerts
- Lilly will aim for one $1bn-$5bn deal per quarter in 2020
- Novartis gets EU approval for multiple sclerosis therapy Mayzent
- Immuno-oncology, personalised medicine continues to drive pharma sector
- NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi
- FDA delays decision on Intercept's NASH drug by three months
- Novartis gets EU approval for multiple sclerosis therapy Mayzent
- New coronavirus sees drug developers scramble to develop a vaccine
- Sanofi completes acquisition of immuno-oncology specialist Synthorx
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- Epizyme wins FDA approval for epithelioid sarcoma treatment
- Pharma Brand Planners' Blog (Part 8)
- Happy Chinese New Year 2020 - The Year of The Rat
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- Happy Chinese New Year 2020 - The Year of The Rat
- A fond farewell to The Year of the Pig...
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Quick links
Infographics
